At last, a RE-LYable alternative to warfarin for atrial fibrillation

G J Hankey

doi:10.1111/j.1747-4949.2009.00389.x

At last, a RE-LYable alternative to warfarin for atrial fibrillation

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	454-5
Number of pages	2
Journal	International Journal of Stroke
Volume	4
Issue number	6
DOIs	https://doi.org/10.1111/j.1747-4949.2009.00389.x
Publication status	Published - Dec 2009

Access to Document

10.1111/j.1747-4949.2009.00389.x

Cite this

@article{9baa279dd2be4189a6d1586b501c949a,

title = "At last, a RE-LYable alternative to warfarin for atrial fibrillation",

keywords = "Anticoagulants/adverse effects, Atrial Fibrillation/complications, Benzimidazoles/adverse effects, Dabigatran, Dyspepsia/chemically induced, Hemorrhage/chemically induced, Humans, Multicenter Studies as Topic, Prospective Studies, Pyridines/adverse effects, Randomized Controlled Trials as Topic, Warfarin/adverse effects",

author = "Hankey, {G J}",

year = "2009",

month = dec,

doi = "10.1111/j.1747-4949.2009.00389.x",

language = "English",

volume = "4",

pages = "454--5",

journal = "International Journal of Stroke",

issn = "1747-4930",

publisher = "Wiley-Blackwell",

number = "6",

}

TY - JOUR

T1 - At last, a RE-LYable alternative to warfarin for atrial fibrillation

AU - Hankey, G J

PY - 2009/12

Y1 - 2009/12

KW - Anticoagulants/adverse effects

KW - Atrial Fibrillation/complications

KW - Benzimidazoles/adverse effects

KW - Dabigatran

KW - Dyspepsia/chemically induced

KW - Hemorrhage/chemically induced

KW - Humans

KW - Multicenter Studies as Topic

KW - Prospective Studies

KW - Pyridines/adverse effects

KW - Randomized Controlled Trials as Topic

KW - Warfarin/adverse effects

U2 - 10.1111/j.1747-4949.2009.00389.x

DO - 10.1111/j.1747-4949.2009.00389.x

M3 - Article

C2 - 19930055

VL - 4

SP - 454

EP - 455

JO - International Journal of Stroke

JF - International Journal of Stroke

SN - 1747-4930

IS - 6

ER -